Medigene AG Odds of Future Pink Sheet Price Finishing Over 1.88

MDGEFDelisted Stock  USD 2.59  0.00  0.00%   
Medigene's future price is the expected price of Medigene instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Medigene AG performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
  
Please specify Medigene's target price for which you would like Medigene odds to be computed.

Medigene Target Price Odds to finish over 1.88

The tendency of Medigene Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 1.88  in 90 days
 2.59 90 days 1.88 
about 67.91
Based on a normal probability distribution, the odds of Medigene to stay above $ 1.88  in 90 days from now is about 67.91 (This Medigene AG probability density function shows the probability of Medigene Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Medigene AG price to stay between $ 1.88  and its current price of $2.59 at the end of the 90-day period is about 56.12 .
Assuming the 90 days horizon Medigene AG has a beta of -1.59. This indicates as returns on its benchmark rise, returns on holding Medigene AG are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Medigene is expected to outperform its benchmark. Moreover Medigene AG has an alpha of 1.1803, implying that it can generate a 1.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Medigene Price Density   
       Price  

Predictive Modules for Medigene

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medigene AG. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medigene's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.592.592.59
Details
Intrinsic
Valuation
LowRealHigh
1.881.882.85
Details
Naive
Forecast
LowNextHigh
3.733.733.73
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.301.683.05
Details

Medigene Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Medigene is not an exception. The market had few large corrections towards the Medigene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medigene AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medigene within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.18
β
Beta against Dow Jones-1.59
σ
Overall volatility
0.43
Ir
Information ratio 0.06

Medigene Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medigene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medigene AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Medigene AG is not yet fully synchronised with the market data
Medigene AG has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 10.46 M. Net Loss for the year was (9.98 M) with profit before overhead, payroll, taxes, and interest of 9.1 M.
Medigene AG has accumulated about 39.38 M in cash with (10.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.6.

Medigene Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medigene Pink Sheet often depends not only on the future outlook of the current and potential Medigene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medigene's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding24.6 M

Medigene Technical Analysis

Medigene's future price can be derived by breaking down and analyzing its technical indicators over time. Medigene Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medigene AG. In general, you should focus on analyzing Medigene Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Medigene Predictive Forecast Models

Medigene's time-series forecasting models is one of many Medigene's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medigene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Medigene AG

Checking the ongoing alerts about Medigene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medigene AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Medigene AG is not yet fully synchronised with the market data
Medigene AG has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 10.46 M. Net Loss for the year was (9.98 M) with profit before overhead, payroll, taxes, and interest of 9.1 M.
Medigene AG has accumulated about 39.38 M in cash with (10.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.6.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Medigene Pink Sheet

If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing